ES8802182A1 - Un procedimiento para preparar una linfotoxina. - Google Patents
Un procedimiento para preparar una linfotoxina.Info
- Publication number
- ES8802182A1 ES8802182A1 ES543695A ES543695A ES8802182A1 ES 8802182 A1 ES8802182 A1 ES 8802182A1 ES 543695 A ES543695 A ES 543695A ES 543695 A ES543695 A ES 543695A ES 8802182 A1 ES8802182 A1 ES 8802182A1
- Authority
- ES
- Spain
- Prior art keywords
- lymphotoxin
- nucleic acid
- encoding
- new
- dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 102000004083 Lymphotoxin-alpha Human genes 0.000 title abstract 6
- 108090000542 Lymphotoxin-alpha Proteins 0.000 title abstract 6
- 108020004707 nucleic acids Proteins 0.000 title abstract 6
- 102000039446 nucleic acids Human genes 0.000 title abstract 6
- 150000007523 nucleic acids Chemical class 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 2
- 239000013598 vector Substances 0.000 title abstract 2
- 230000003472 neutralizing effect Effects 0.000 title 1
- 108020004414 DNA Proteins 0.000 abstract 5
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 108091092195 Intron Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 238000004113 cell culture Methods 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
- C07K16/242—Lymphotoxin [LT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
- C07K14/5255—Lymphotoxin [LT]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61650384A | 1984-05-31 | 1984-05-31 | |
| US06/616,502 US4959457A (en) | 1984-05-31 | 1984-05-31 | Anti-lymphotoxin |
| US73231285A | 1985-05-09 | 1985-05-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8802182A1 true ES8802182A1 (es) | 1988-04-16 |
| ES543695A0 ES543695A0 (es) | 1988-04-16 |
Family
ID=27417179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES543695A Expired ES8802182A1 (es) | 1984-05-31 | 1985-05-30 | Un procedimiento para preparar una linfotoxina. |
Country Status (23)
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU564690B2 (en) | 1980-04-03 | 1987-08-20 | Biogen Idec Ma Inc. | Process for producing human fibroblast interferon-like polypeptides using recombinant dna |
| US5683688A (en) | 1984-05-31 | 1997-11-04 | Genentech, Inc. | Unglycosylated recombinant human lymphotoxin polypeptides and compositions |
| NZ212207A (en) | 1984-05-31 | 1991-07-26 | Genentech Inc | Recombinant lymphotoxin |
| IL73883A (en) * | 1984-12-20 | 1990-12-23 | Yeda Res & Dev | Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha |
| WO1986003751A2 (en) * | 1984-12-21 | 1986-07-03 | Biogen N.V. | Purification, production and use of tumor necrosis factors |
| JPS62111928A (ja) * | 1985-10-15 | 1987-05-22 | Kanegafuchi Chem Ind Co Ltd | 新規リンホトキシン |
| JPS62195285A (ja) * | 1986-02-19 | 1987-08-28 | Kanegafuchi Chem Ind Co Ltd | リンホトキシン発現ベクタ−及びそれを用いるリンホトキシンの製造方法 |
| AU603768B2 (en) * | 1985-07-04 | 1990-11-29 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Lymphotoxin dna, lymphotoxin expression vector, lymphotoxin resistant cell, transformant with lymphotoxin expression vector and process for preparing lymphotoxin |
| DE3686148T2 (de) * | 1985-12-24 | 1993-01-14 | Denki Kagaku Kogyo Kk | Lymphotoxin-gen, verfahren zu dessen herstellung und lymphotoxin. |
| JP2548204B2 (ja) * | 1987-06-27 | 1996-10-30 | 電気化学工業株式会社 | 新生理活性ポリペプチド |
| US5403725A (en) * | 1985-12-24 | 1995-04-04 | Denki Kagaku Kogyo Kabushiki Kaisha | Method for production of lymphotoxin (TNFB) in cell line A-C5-8 |
| EP0230574A3 (en) * | 1986-01-31 | 1989-03-22 | Yale University | Pharmaceutical compositions against infections caused by lav/htlv iii virus and the use thereof |
| JPS62181298A (ja) * | 1986-02-05 | 1987-08-08 | Kyowa Hakko Kogyo Co Ltd | ヒトリンホトキシンポリペプチド誘導体 |
| DE3620656A1 (de) * | 1986-06-20 | 1987-12-23 | Basf Ag | Polypeptide mit lymphotoxin-aktivitaet oder lymphotoxin-aehnlicher aktivitaet, ihre herstellung und verwendung |
| JPS63105680A (ja) * | 1986-10-22 | 1988-05-10 | Kanegafuchi Chem Ind Co Ltd | ヒト・リンホトキシン発現ベクタ−、該発現ベクタ−による形質転換細胞および該細胞を用いるリンホトキシンの製造方法 |
| EP0272894A3 (en) * | 1986-12-24 | 1989-06-14 | Takeda Chemical Industries, Ltd. | Recombinant human lymphotoxin |
| US5175268A (en) * | 1986-12-24 | 1992-12-29 | Takeda Chemical Industries, Ltd. | DNA encoding recombinant human lymphotoxin |
| FI884798A7 (fi) * | 1987-10-28 | 1989-04-29 | Eisai Co Ltd | Rekombinantlymfotoxin. |
| DE3837012A1 (de) * | 1988-01-15 | 1989-07-27 | Knoll Ag | Verwendung von tnf und lt zur herstellung von arzneimitteln |
| GB2217326B (en) * | 1988-04-08 | 1991-11-20 | British Bio Technology | Synthetic gene encoding human tumour necrosis factor beta. |
| EP0338497A3 (en) * | 1988-04-22 | 1990-05-16 | Takeda Chemical Industries, Ltd. | Bispecific hybrid monoclonal antibody |
| JPH023698A (ja) * | 1988-06-20 | 1990-01-09 | Denki Kagaku Kogyo Kk | ヒトリンホトキシンに対するモノクローナル抗体及びそれら抗体を産生するハイブリドーマ、並びにそれら抗体を用いたヒトリンホトキシンの精製方法、測定方法及び測定試薬 |
| CA2001756A1 (en) * | 1988-10-31 | 1991-04-30 | Seiichi Uesugi | New human lymphotoxin n-end deletion mutant |
| JPH03106821A (ja) * | 1989-09-20 | 1991-05-07 | Denki Kagaku Kogyo Kk | 抗腫瘍剤 |
| US5200176A (en) * | 1989-10-06 | 1993-04-06 | Genentech, Inc. | Method for protection of ischemic tissues using tumor nerosis factor |
| US5370870A (en) * | 1989-10-06 | 1994-12-06 | Genentech, Inc. | Method for protection against reactive oxygen species |
| IL97779A (en) * | 1990-04-10 | 2000-01-31 | Genentech Inc | Compositions for cytoprotection against radiation and chemotherapy injury or risk thereof |
| US5747023A (en) * | 1994-07-01 | 1998-05-05 | Genentech, Inc. | Cancer therapy using lymphotoxin |
| JP4231106B2 (ja) * | 1995-01-23 | 2009-02-25 | ゼノテック インコーポレイティッド | 骨溶解および転移を改善する方法 |
| US5925351A (en) | 1995-07-21 | 1999-07-20 | Biogen, Inc. | Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| US6998116B1 (en) | 1996-01-09 | 2006-02-14 | Genentech, Inc. | Apo-2 ligand |
| ES2316182T3 (es) | 1998-01-15 | 2009-04-01 | Genentech, Inc. | Ligando apo-2. |
| EP2314676A1 (en) * | 2002-11-26 | 2011-04-27 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| EP1641826A2 (en) | 2003-06-27 | 2006-04-05 | Biogen Idec MA Inc. | Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions |
| EP1699486A4 (en) * | 2003-12-08 | 2007-07-18 | Centocor Inc | ANTI-LYMPHOTOXIN HUMAN ALPHA ANTIBODIES, COMPOSITIONS, METHODS AND USES |
| BRPI0509201A (pt) | 2004-03-23 | 2007-08-28 | Biogen Idec Inc | agentes de acoplamento de receptor e usos terapêuticos destes |
| WO2006074399A2 (en) | 2005-01-05 | 2006-07-13 | Biogen Idec Ma Inc. | Multispecific binding molecules comprising connecting peptides |
| CL2007002926A1 (es) * | 2006-10-12 | 2008-05-16 | Genentech Inc | Anticuerpo antilinfotoxina alfa (lt-alfa); composicion con el anticuerpo; hibridoma pta-7538; acido nucleico codificante del anticuerpo; vector y celula huesped que comprenden el acido nucleico; metodo para inhibir la proliferacion celular activada p |
| EP2311481A3 (en) | 2006-10-20 | 2013-10-16 | Biogen Idec MA Inc. | Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor |
| US8338376B2 (en) | 2006-10-20 | 2012-12-25 | Biogen Idec Ma Inc. | Compositions comprising variant LT-B-R-IG fusion proteins |
| UA122204C2 (uk) * | 2014-04-25 | 2020-10-12 | Наурекс, Інк. | Стабільні композиції нейроактивних пептидів |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN151589B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1978-12-22 | 1983-05-28 | Biogen Nv | |
| NZ201918A (en) | 1981-09-18 | 1987-04-30 | Genentech Inc | N-terminal methionyl analogues of bovine growth hormone |
| ZA834976B (en) * | 1982-07-30 | 1984-08-29 | Genentech Inc | Human lymphotoxin |
| IE56026B1 (en) | 1982-10-19 | 1991-03-27 | Cetus Corp | Cysteine-depleted muteins of biologically active proteins |
| EP0135797A3 (de) * | 1983-08-30 | 1987-11-11 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Verfahren zur Herstellung von Lymphotoxin und von Lymphotoxin-mRNA |
| DE3331108A1 (de) * | 1983-08-30 | 1985-05-02 | Boehringer Ingelheim International GmbH, 6507 Ingelheim | Verfahren zur herstellung von lymphotoxin und von lymphotoxin-mrna |
| NZ212207A (en) | 1984-05-31 | 1991-07-26 | Genentech Inc | Recombinant lymphotoxin |
-
1985
- 1985-05-27 NZ NZ212207A patent/NZ212207A/en unknown
- 1985-05-27 IL IL7531885A patent/IL75318A/en unknown
- 1985-05-28 IE IE132185A patent/IE63487B1/en not_active IP Right Cessation
- 1985-05-29 FI FI852143A patent/FI93025C/fi not_active IP Right Cessation
- 1985-05-29 GR GR851317A patent/GR851317B/el unknown
- 1985-05-30 EP EP92110196A patent/EP0509553B1/en not_active Expired - Lifetime
- 1985-05-30 HU HU852076A patent/HU204085B/hu unknown
- 1985-05-30 BG BG070460A patent/BG60256B1/bg unknown
- 1985-05-30 ES ES543695A patent/ES8802182A1/es not_active Expired
- 1985-05-30 AT AT92110196T patent/ATE195323T1/de not_active IP Right Cessation
- 1985-05-30 DE DE3587597T patent/DE3587597T2/de not_active Expired - Lifetime
- 1985-05-30 DE DE3588225T patent/DE3588225T2/de not_active Expired - Lifetime
- 1985-05-30 NO NO852173A patent/NO179075C/no unknown
- 1985-05-30 DK DK241385A patent/DK171531B1/da not_active IP Right Cessation
- 1985-05-30 AT AT85303818T patent/ATE95243T1/de not_active IP Right Cessation
- 1985-05-30 EP EP85303818A patent/EP0164965B1/en not_active Expired - Lifetime
- 1985-05-31 SK SK3930-85A patent/SK278333B6/sk unknown
- 1985-05-31 AU AU43203/85A patent/AU599303B2/en not_active Expired
- 1985-05-31 JP JP60119648A patent/JP2521703B2/ja not_active Expired - Lifetime
- 1985-05-31 PT PT80573A patent/PT80573B/pt unknown
- 1985-05-31 YU YU91985A patent/YU47735B/sh unknown
- 1985-05-31 CZ CS853930A patent/CZ283148B6/cs not_active IP Right Cessation
- 1985-05-31 CA CA000482995A patent/CA1340641C/en not_active Expired - Lifetime
- 1985-05-31 PL PL1985253739A patent/PL155410B1/pl unknown
-
1986
- 1986-10-14 AR AR86305572A patent/AR245219A1/es active
-
1988
- 1988-01-19 RO RO131846A patent/RO100383A2/ro unknown
-
1995
- 1995-01-19 JP JP7006657A patent/JPH07291995A/ja active Pending
- 1995-01-19 JP JP7006665A patent/JP2804237B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8802182A1 (es) | Un procedimiento para preparar una linfotoxina. | |
| Azuma et al. | Cloning of cDNA for human T-cell replacing factor (interieukin-5) and comparison with the murine homologue | |
| Xie et al. | Cloning and characterization of inducible nitric oxide synthase from mouse macrophages | |
| Bennett et al. | Molecular cloning and complete amino-acid sequence of form-I phosphoinositide-specific phospholipase C | |
| Gillies et al. | Cell type-specific enhancer element associated with a mouse MHC gene, Eβ | |
| KR910002692B1 (ko) | 수정 호르몬의 제조방법 | |
| Cameron et al. | Purification to homogeneity and amino acid sequence analysis of two anionic species of human interleukin 1. | |
| DE69131321D1 (de) | Mutationen in der 5'-3'-exonukleaseaktivität thermostabiler dna-polymerasen | |
| ES2009238A6 (es) | Metodo para producir proteinas de mycobacterium tuberculosis y peptidos antigenicos de las mismas. | |
| AP1678A (en) | Novel modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems. | |
| Silen et al. | Molecular analysis of the gene encoding α-lytic protease: evidence for a preproenzyme | |
| ATE133681T1 (de) | Mykobakterielle rekombinanten und peptide | |
| KR850004274A (ko) | 에리트로포이에틴의 제조방법 | |
| CA2257839A1 (en) | Gamma-heregulin | |
| JP3009381B2 (ja) | 成熟ヒト インターロイキン１ | |
| IL88151A (en) | Interleukin-7 protein, dna sequences encoding it, its preparation and compositions containing it | |
| KR880007568A (ko) | 말의 감마-인터페론 | |
| CA2461443A1 (en) | Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use | |
| NZ503235A (en) | Amino-terminally truncated RANTES as chemokine antagonists | |
| EP0973794A4 (en) | NETRIN RECEPTORS | |
| Stewart et al. | Structure of an interferon-α2 gene expressed in the bovine conceptus early in gestation | |
| Liu et al. | Production of a biologically active human interleukin 18 requires its prior synthesis as PRO-IL-18 | |
| EP0111814A3 (en) | The cloning and expression of nucleotide sequences encoding bovine growth hormone | |
| NZ334568A (en) | Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof | |
| Goto et al. | Interleukin-1 receptor antagonist in inflammatory exudate cells of rabbits. Production, purification and determination of primary structure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD2A | Announcement of lapse in spain |
Effective date: 20151230 |